Steven L. Hoerter's most recent trade in C4 Therapeutics Inc was a trade of 65,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| C4 Therapeutics Inc | Steven L. Hoerter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| ORIC Pharma Inc | Steven L. Hoerter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 25,600 | 25,600 | - | - | Stock Option (right to buy) | |
| Deciphera Pharmaceuticals Inc | Hoerter Steven L. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 298,100 | 298,100 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Steven L. Hoerter | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 62,500 | 103,427 (0%) | 0% | - | Common Stock | |
| Deciphera Pharmaceuticals Inc | L. Steven Hoerter | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.37 per share. | 12 Dec 2023 | 30,664 | 72,763 (0%) | 0% | 15.4 | 471,217 | Common Stock |
| ORIC Pharma Inc | Steven L. Hoerter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 20,500 | 20,500 | - | - | Stock Option (right to buy) | |
| Deciphera Pharmaceuticals Inc | Steven L. Hoerter | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.57 per share. | 21 Mar 2023 | 7,500 | 0 (0%) | 0% | 15.6 | 116,782 | Common Stock |
| Deciphera Pharmaceuticals Inc | Steven L. Hoerter | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Steven L. Hoerter | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 14 Feb 2023 | 30,045 | 7,500 (0%) | 0% | 16 | 480,720 | Common Stock |
| Deciphera Pharmaceuticals Inc | Steven L. Hoerter | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.11 per share. | 21 Mar 2022 | 3,150 | 37,545 (0%) | 0% | 9.1 | 28,697 | Common Stock |
| Deciphera Pharmaceuticals Inc | Steven L. Hoerter | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 415,000 | 415,000 | - | - | Stock Option (Right to Buy) | |
| ORIC Pharma Inc | Steven L. Hoerter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2021 | 33,250 | 33,250 | - | - | Stock Option (right to buy) |